<DOC>
	<DOC>NCT00403078</DOC>
	<brief_summary>The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease. The devices to be utilized are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).</brief_summary>
	<brief_title>SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy</brief_title>
	<detailed_description>Carotid Artery Stenting</detailed_description>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Highsurgical risk patients to be treated consistent with IFU labeling The patient or legally authorized representative has signed a written informed consent and HIPAA authorization, prior to the procedure, using a form that is approved by the Institutional Review Board or Medical Ethics Committee. Patients not treated per the IFU Patients who are contraindicated per the IFU Patients previously enrolled in the study Patients requiring stenting of instent restenosis after CAS Inability or refusal to provide informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Carotid Artery Stenting (Endovascular)</keyword>
</DOC>